The Journal of Heart and Lung Transplantation
Volume 25, Issue 3 , Pages 302-309 , March 2006

Efficacy of Mycophenolic Acid Combined With KRP-203, a Novel Immunomodulator, in a Rat Heart Transplantation Model

  • Chihiro Suzuki, MD

      Affiliations

    • Division of Cardiovascular Science, Department of Organ Regeneration, Shinshu University Graduate School of Medicine, Matsumoto, Japan
  • ,
  • Masafumi Takahashi, MD, PhD

      Affiliations

    • Division of Cardiovascular Science, Department of Organ Regeneration, Shinshu University Graduate School of Medicine, Matsumoto, Japan
    • Division of Organ Replacement Research, Center for Molecular Medicine, Jichi Medical School, Tochigi, Japan
    • Corresponding Author InformationReprint requests: Masafumi Takahashi, MD, PhD, Department of Organ Regeneration, Shinshu University Graduate School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan. Telephone: +81-263-37-3352. Fax: +81-63-37-2573
  • ,
  • Hajime Morimoto, DVM

      Affiliations

    • Division of Cardiovascular Science, Department of Organ Regeneration, Shinshu University Graduate School of Medicine, Matsumoto, Japan
  • ,
  • Atsushi Izawa, MD, PhD

      Affiliations

    • Division of Cardiovascular Science, Department of Organ Regeneration, Shinshu University Graduate School of Medicine, Matsumoto, Japan
  • ,
  • Hirohiko Ise, PhD

      Affiliations

    • Division of Cardiovascular Science, Department of Organ Regeneration, Shinshu University Graduate School of Medicine, Matsumoto, Japan
  • ,
  • Jun Fujishiro, MD

      Affiliations

    • Division of Organ Replacement Research, Center for Molecular Medicine, Jichi Medical School, Tochigi, Japan
  • ,
  • Takashi Murakami, MD, PhD

      Affiliations

    • Division of Organ Replacement Research, Center for Molecular Medicine, Jichi Medical School, Tochigi, Japan
  • ,
  • Junichi Ishiyama, MSc

      Affiliations

    • Discovery Research Laboratories, Kyorin Pharmaceutical Co., Ltd, Tochigi, Japan
  • ,
  • Akihiro Nakada, MSc

      Affiliations

    • Discovery Research Laboratories, Kyorin Pharmaceutical Co., Ltd, Tochigi, Japan
  • ,
  • Jun Nakayama, MD, PhD

      Affiliations

    • Department of Pathology, Shinshu University Graduate School of Medicine, Matsumoto, Japan
  • ,
  • Kazuyuki Shimada, MD, PhD

      Affiliations

    • Division of Cardiovascular Medicine, Department of Internal Medicine, Jichi Medical School, Tochigi, Japan
  • ,
  • Uichi Ikeda, MD, PhD

      Affiliations

    • Division of Cardiovascular Science, Department of Organ Regeneration, Shinshu University Graduate School of Medicine, Matsumoto, Japan
  • ,
  • Eiji Kobayashi, MD, PhD

      Affiliations

    • Division of Organ Replacement Research, Center for Molecular Medicine, Jichi Medical School, Tochigi, Japan

Received 11 July 2005 ,Revised 19 September 2005 ,Accepted 22 September 2005.

References 

  1. Eisen H , Ross H . Optimizing the immunosuppressive regimen in heart transplantation . J Heart Lung Transplant . 2004;23:S207–S213
  2. Azuma H , Tilney NL . Chronic graft rejection . Curr Opin Immunol . 1994;6:770–776
  3. Hillebrands JL , Rozing J . Chronic transplant dysfunction and transplant arteriosclerosis (new insights into underlying mechanisms) . Expert Rev Mol Med . 2003;2003:1–23
  4. Stepkowski SM . Molecular targets for existing and novel immunosuppressive drugs . Expert Rev Mol Med . 2000;2000:1–23
  5. Olyaei AJ , de Mattos AM , Bennett WM . Nephrotoxicity of immunosuppressive drugs (new insight and preventive strategies) . Curr Opin Crit Care . 2001;7:384–389
  6. Bennett WM , DeMattos A , Meyer MM , Andoh T , Barry JM . Chronic cyclosporine nephropathy (the Achilles’ heel of immunosuppressive therapy) . Kidney Int . 1996;50:1089–1100
  7. Sander M , Victor RG . Hypertension after cardiac transplantation (pathophysiology and management) . Curr Opin Nephrol Hypertens . 1995;4:443–451
  8. Moore R , Hernandez D , Valantine H . Calcineurin inhibitors and post-transplant hyperlipidaemias . Drug Saf . 2001;24:755–766
  9. Shimizu H , Takahashi M , Kaneko T , et al.   KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts . Circulation . 2005;111:222–229
  10. Takahashi M , Shimizu H , Murakami T , et al.   A novel immunomodulator KRP-203 combined with cyclosporine prolonged graft survival and abrogated transplant vasculopathy in rat heart allografts . Transplant Proc . 2005;37:143–145
  11. Mele TS , Halloran PF . The use of mycophenolate mofetil in transplant recipients . Immunopharmacology . 2000;47:215–245
  12. European Mycophenolate Mofetil Cooperative Study Group . Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection . Lancet . 1995;345:1321–1325
  13. Hollander AA , van Saase JL , Kootte AM , et al.   Beneficial effects of conversion from cyclosporin to azathioprine after kidney transplantation . Lancet . 1995;345:610–614
  14. Xiu D , Uchida H , To H , et al.   Simplified method of heterotopic rat heart transplantation using the cuff technique (application to sublethal dose protocol of methotrexate on allograft survival) . Microsurgery . 2001;21:16–21
  15. Brinkmann V , Davis MD , Heise CE , et al.   The immune modulator FTY720 targets sphingosine 1-phosphate receptors . J Biol Chem . 2002;277:21453–21457
  16. Yamaguchi A , Miniati DN , Hirata K , Hoyt EG , Robbins RC . Ex vivo blockade of endothelin-1 inhibits graft coronary artery disease in a rodent cardiac allograft model . J Heart Lung Transplant . 2002;21:417–424
  17. Simonson MS , Herman WH , Robinson A , Schulak J , Hricik DE . Inhibition of endothelin-converting enzyme attenuates transplant vasculopathy and rejection in rat cardiac allografts . Transplantation . 1999;67:1542–1547
  18. Sihvola RK , Pulkkinen VP , Koskinen PK , Lemstrom KB . Crosstalk of endothelin-1 and platelet-derived growth factor in cardiac allograft arteriosclerosis . JAMA . 2002;39:710–717
  19. Little DM , Haynes LD , Alam T , Geraghty JG , Sollinger HW , Hullett DA . Does transforming growth factor beta 1 play a role in the pathogenesis of chronic allograft rejection? . Transpl Int . 1999;12:393–401
  20. Lijnen PJ , Petrov VV , Fagard RH . Induction of cardiac fibrosis by transforming growth factor-beta(1) . Mol Genet Metab . 2000;71:418–435
  21. Russell ME . Macrophages and transplant arteriosclerosis (known and novel molecules) . J Heart Lung Transplant . 1995;14:S111–S115
  22. Kown MH , Jahncke CL , Lijkwan MA , et al.   The use of (99m) technetium-labeled MCP-1 to assess graft coronary artery disease in rat cardiac allografts . J Heart Lung Transplant . 2002;21:1009–1015
  23. Joucher F , Mazmanian GM , German-Fattal M . E-selectin early overexpression induced by allogeneic activation in isolated mouse lung . Transplantation . 2004;78:1283–1289
  24. Shimizu H , Takahashi M , Takeda S , et al.   Mycophenolate mofetil prevents transplant arteriosclerosis by direct inhibition of vascular smooth muscle cell proliferation . Transplantation . 2004;77:1661–1667
  25. Shimizu H , Takahashi M , Takeda S , et al.   Conversion from cyclosporine A to mycophenolate mofetil protects recipient kidney and prevents intimal hyperplasia in rat aortic allografts . Transpl Immunol . 2004;13:219–227
  26. Hauser IA , Renders L , Radeke HH , Sterzel RB , Goppelt-Struebe M . Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion . Nephrol Dial Transplant . 1999;14:58–63
  27. Moon JI , Kim YS , Kim MS , et al.   Effect of cyclosporine, mycophenolic acid, and rapamycin on the proliferation of rat aortic vascular smooth muscle cells (in vitro study) . Transplant Proc . 2000;32:2026–2027
  28. Heemann U , Azuma H , Hamar P , Schmid C , Tilney N , Philipp T . Mycophenolate mofetil inhibits lymphocyte binding and the upregulation of adhesion molecules in acute rejection of rat kidney allografts . Transpl Immunol . 1996;4:64–67
  29. Rose ML , Smith J , Dureau G , Keogh A , Kobashigowa J . Mycophenolate mofetil decreases antibody production after cardiac transplantation . J Heart Lung Transplant . 2002;21:282–285
  30. Eisen HJ , Kobashigawa J , Keogh A , et al.   Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients . J Heart Lung Transplant . 2005;24:517–525
  31. Klupp J , van Gelder T , Dambrin C , et al.   Sustained suppression of peripheral blood immune functions by treatment with mycophenolate mofetil correlates with reduced severity of cardiac allograft rejection . J Heart Lung Transplant . 2004;23:334–351
  32. Takeda S , Takahashi M , Sado Y , et al.   Prevention of glomerular crescent formation in glomerulonephritis by mycophenolate mofetil in rats . Nephrol Dial Transplant . 2004;19:2228–2236
  33. Takeda S , Takahashi M , Kusano E , Kobayashi E . Mycophenolate mofetil prevents development of urinary protein in autoimmune nephritis . Kidney Int . 2003;64:365–366
  34. McVerry BJ , Garcia JG . In vitro and in vivo modulation of vascular barrier integrity by sphingosine 1-phosphate (mechanistic insights) . Cell Signal . 2005;17:131–139
  35. Picard N , Cresteil T , Premaud A , Marquet P . Characterization of a phase 1 metabolite of mycophenolic acid produced by CYP3A4/5 . Ther Drug Monit . 2004;26:600–608
  36. Budde K , Schmouder RL , Brunkhorst R , et al.   First human trial of FTY720, a novel immunomodulator, in stable renal transplant patients . J Am Soc Nephrol . 2002;13:1073–1083
  37. Sanna MG , Liao J , Jo E , et al.   Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate . J Biol Chem . 2004;279:13839–13848

 This study was supported by research grants from the Ministry of Education, Science, Sports and Culture (#16590667 to M.T. and #16590625 to E.K.) and Daiwa Securities Health Foundation (M.T.).

PII: S1053-2498(05)00748-5

doi: 10.1016/j.healun.2005.09.021

The Journal of Heart and Lung Transplantation
Volume 25, Issue 3 , Pages 302-309 , March 2006